Sodium-glucose cotransporter-2 (SGLT2) inhibitors, a class of diabetes drugs also known as gliflozins, could lower the risk ...

A study published Wednesday in Nature Neuroscience sheds light into how amyloid-beta and tau proteins impact brain activity ...

As life plan communities seek to best position themselves to capture future demand, many are honing growth strategies, including swapping skilled nursing ...

Despite enormous effort, disease-modifying therapies for Alzheimer's disease, the most common cause of dementia, have proven ...

Alzheimer’s disease is a serious condition that affects millions of people worldwide. It causes memory loss, confusion, and ...

The Pilot Club of Baytown has coordinated the Alzheimer’s Walk in Baytown since 1998. Delores Ellis has raised over $800 for ...

Copyright: © 2024 Published by Elsevier Ltd. As the global population ages, Alzheimer's disease and other forms of dementia ...

It’s one of the biggest fundraisers in the fight against Alzheimer’s. This year’s Walk to End Alzheimer’s will take place at ...

A study more closely links obesity to dementia, finding that leptin, a hormone that helps maintain normal body weight, is associated with better signal-transmitting brain white matter in middle-aged ...

A class of drugs for diabetes may be associated with a lower risk of dementia and Parkinson's disease, according to a new study.

Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 ...

TUCSON, Ariz. (13 News)—The Banner Alzheimer’s Institute hosted a senior health resource fair on Tuesday, Sept. 17, to increase awareness of brain health and Alzheimer’s prevention and awareness.